A phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338

Vivek Roy, Barbara A. Pockaj, Jacob B. Allred, Heidi Apsey, Donald W. Northfelt, Daniel Nikcevich, Bassam Mattar, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338'. Together they form a unique fingerprint.

Medicine & Life Sciences